Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06962904 · ClinicalTrials.gov registry record · Phase 1
CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults
A Phase 1 study of Rotavirus Infections, sponsored by Centers for Disease Control and Prevention.
- Active
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06962904 is a Phase 1 study of Rotavirus Infections that is active but no longer recruiting, run by Centers for Disease Control and Prevention. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06962904, a Phase 1 study of Rotavirus Infections, is active but no longer recruiting, sponsored by Centers for Disease Control and Prevention.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study of CDC-9 inactivated rotavirus vaccine (IRV) microneedle patch (MNP) for intradermal administration in healthy adults aged 18 to 45 years at two dose levels in a 3-dose series. The purpose is to determine if it is safe and if the recipient's immune system responds to the vaccine.
Conditions Studied
Interventions
- OTHER Placebo
- BIOLOGICAL 3.75 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)
- BIOLOGICAL 7.5 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)
Study Locations (1)
Georgia
- Emory Children's Center - Vaccine Research Clinic - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-07-07 |
| Est. Completion | 2026-10-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06962904
The ClinicalTrials.gov registry entry for NCT06962904 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rotavirus Infections appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06962904 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT06962904 about?
NCT06962904 is a clinical study titled "CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults". This is a study of CDC-9 inactivated rotavirus vaccine (IRV) microneedle patch (MNP) for intradermal administration in healthy adults aged 18 to 45 years at two dose levels in a 3-dose series. The purpose is to determine if it is safe and if the recipient's immune system responds to the vaccine.
What is the current status of trial NCT06962904?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2025-07-07. Estimated completion is 2026-10-06.
What conditions does trial NCT06962904 study?
This clinical trial studies the following conditions: Rotavirus Infections.
What interventions are being tested in trial NCT06962904?
The interventions under investigation include: Placebo (OTHER), 3.75 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV) (BIOLOGICAL), 7.5 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV) (BIOLOGICAL).
Who is sponsoring clinical trial NCT06962904?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06962904 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.